Reply to D. de Fonseka et al.

Autor: Kindler HL; Hedy L. Kindler, The University of Chicago, Chicago, IL; Valerie Rusch, Memorial Sloan Kettering Cancer Center, New York NY; Raphael Bueno, Harvard Medical School, Boston, MA; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria VA; Harvey Pass and Daniel Sterman, New York University Langone Medical Center, New York, NY; and Raffit Hassan, National Cancer Institute, Bethesda, MD., Rusch V; Hedy L. Kindler, The University of Chicago, Chicago, IL; Valerie Rusch, Memorial Sloan Kettering Cancer Center, New York NY; Raphael Bueno, Harvard Medical School, Boston, MA; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria VA; Harvey Pass and Daniel Sterman, New York University Langone Medical Center, New York, NY; and Raffit Hassan, National Cancer Institute, Bethesda, MD., Bueno R; Hedy L. Kindler, The University of Chicago, Chicago, IL; Valerie Rusch, Memorial Sloan Kettering Cancer Center, New York NY; Raphael Bueno, Harvard Medical School, Boston, MA; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria VA; Harvey Pass and Daniel Sterman, New York University Langone Medical Center, New York, NY; and Raffit Hassan, National Cancer Institute, Bethesda, MD., Ismaila N; Hedy L. Kindler, The University of Chicago, Chicago, IL; Valerie Rusch, Memorial Sloan Kettering Cancer Center, New York NY; Raphael Bueno, Harvard Medical School, Boston, MA; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria VA; Harvey Pass and Daniel Sterman, New York University Langone Medical Center, New York, NY; and Raffit Hassan, National Cancer Institute, Bethesda, MD., Pass H; Hedy L. Kindler, The University of Chicago, Chicago, IL; Valerie Rusch, Memorial Sloan Kettering Cancer Center, New York NY; Raphael Bueno, Harvard Medical School, Boston, MA; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria VA; Harvey Pass and Daniel Sterman, New York University Langone Medical Center, New York, NY; and Raffit Hassan, National Cancer Institute, Bethesda, MD., Sterman D; Hedy L. Kindler, The University of Chicago, Chicago, IL; Valerie Rusch, Memorial Sloan Kettering Cancer Center, New York NY; Raphael Bueno, Harvard Medical School, Boston, MA; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria VA; Harvey Pass and Daniel Sterman, New York University Langone Medical Center, New York, NY; and Raffit Hassan, National Cancer Institute, Bethesda, MD., Hassan R; Hedy L. Kindler, The University of Chicago, Chicago, IL; Valerie Rusch, Memorial Sloan Kettering Cancer Center, New York NY; Raphael Bueno, Harvard Medical School, Boston, MA; Nofisat Ismaila, American Society of Clinical Oncology, Alexandria VA; Harvey Pass and Daniel Sterman, New York University Langone Medical Center, New York, NY; and Raffit Hassan, National Cancer Institute, Bethesda, MD.
Jazyk: angličtina
Zdroj: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 2018 Sep 10; Vol. 36 (26), pp. 2746-2747. Date of Electronic Publication: 2018 Jun 14.
DOI: 10.1200/JCO.2018.78.7333
Databáze: MEDLINE